Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2
Authors
Keywords
-
Journal
CLINICAL THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-02-05
DOI
10.1016/j.clinthera.2022.01.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
- (2020) Messoud Ashina et al. CEPHALALGIA
- Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study
- (2020) Dawn C. Buse et al. JOURNAL OF HEADACHE AND PAIN
- Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
- (2020) Leon F. Garcia-Martinez et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Migraine, obesity and body fat distribution – a population-based study
- (2020) Espen Saxhaug Kristoffersen et al. JOURNAL OF HEADACHE AND PAIN
- Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
- (2019) Hans-Christoph Diener et al. CEPHALALGIA
- Optimising migraine treatment: from drug-drug interactions to personalized medicine
- (2019) Leda Marina Pomes et al. JOURNAL OF HEADACHE AND PAIN
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
- (2018) Cornelis Smit et al. Expert Opinion on Drug Metabolism & Toxicology
- The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies
- (2018) Rebecca Burch et al. HEADACHE
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Body composition status and the risk of migraine
- (2017) Bizu Gelaye et al. NEUROLOGY
- Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
- (2015) Richard B. Lipton et al. HEADACHE
- The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
- (2014) Aubrey Manack Adams et al. CEPHALALGIA
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search